Holen Sie sich die Stockscreener-App
557.63
1.09%
-6.15
Vorhandelsmarkt:
556.80
-0.83
-0.15%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt TMO?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$563.78
Offen:
$564.13
24-Stunden-Volumen:
992.21K
Relative Volume:
0.46
Marktkapitalisierung:
$210.57B
Einnahmen:
$43.74B
Nettoeinkommen (Verlust:
$6.59B
KGV:
32.23
EPS:
17.3021
Netto-Cashflow:
$6.11B
1W Leistung:
-0.06%
1M Leistung:
+20.12%
6M Leistung:
+32.35%
1J Leistung:
+0.92%
1-Tages-Spanne:
$555.57
$565.65
1-Wochen-Bereich:
$550.88
$578.24
52-Wochen-Spanne:
$385.46
$610.97
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
Firmenname
Thermo Fisher Scientific Inc
Sektor
Branche
Telefon
(781) 622-1000
Adresse
168 THIRD AVENUE, WALTHAM, MA
Vergleichen Sie TMO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
557.63 | 212.89B | 43.74B | 6.59B | 6.11B | 17.30 |
|
DHR
Danaher Corp
|
216.90 | 156.11B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
IDXX
Idexx Laboratories Inc
|
634.36 | 51.80B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
145.85 | 41.56B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
218.13 | 36.96B | 15.70B | 1.24B | 2.01B | 6.9036 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-09-11 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-08-19 | Eingeleitet | William Blair | Outperform |
| 2025-07-24 | Herabstufung | HSBC Securities | Buy → Hold |
| 2025-07-11 | Hochstufung | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | Herabstufung | UBS | Buy → Neutral |
| 2025-01-10 | Hochstufung | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | Eingeleitet | Scotiabank | Sector Perform |
| 2024-10-14 | Eingeleitet | Redburn Atlantic | Buy |
| 2024-10-01 | Eingeleitet | Stephens | Overweight |
| 2024-08-28 | Eingeleitet | Wells Fargo | Overweight |
| 2024-06-03 | Fortgesetzt | Jefferies | Buy |
| 2024-03-18 | Fortgesetzt | Citigroup | Neutral |
| 2024-01-24 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-01-08 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | Eingeleitet | HSBC Securities | Buy |
| 2023-12-13 | Eingeleitet | Wolfe Research | Outperform |
| 2023-10-26 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | Eingeleitet | Bernstein | Outperform |
| 2023-09-06 | Fortgesetzt | Citigroup | Buy |
| 2023-07-19 | Eingeleitet | Raymond James | Outperform |
| 2023-07-19 | Bestätigt | Robert W. Baird | Outperform |
| 2023-07-13 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | Bestätigt | Barclays | Overweight |
| 2022-12-14 | Eingeleitet | Deutsche Bank | Buy |
| 2022-12-07 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2022-10-27 | Herabstufung | The Benchmark Company | Buy → Hold |
| 2022-08-25 | Eingeleitet | Credit Suisse | Neutral |
| 2022-04-25 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | Fortgesetzt | Barclays | Overweight |
| 2021-10-20 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-10-15 | Fortgesetzt | Cowen | Outperform |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-16 | Eingeleitet | The Benchmark Company | Buy |
| 2021-03-18 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | Eingeleitet | Barclays | Overweight |
| 2021-01-08 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | Herabstufung | Citigroup | Buy → Neutral |
| 2020-12-02 | Eingeleitet | Goldman | Buy |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | Eingeleitet | Atlantic Equities | Overweight |
| 2020-09-14 | Eingeleitet | Morgan Stanley | Overweight |
| 2020-08-20 | Fortgesetzt | JP Morgan | Overweight |
| 2020-07-15 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2020-07-07 | Bestätigt | Needham | Buy |
| 2020-04-23 | Bestätigt | Needham | Buy |
| 2020-01-31 | Bestätigt | Needham | Buy |
| 2020-01-22 | Eingeleitet | Credit Suisse | Neutral |
| 2020-01-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-01-07 | Eingeleitet | Citigroup | Buy |
| 2019-11-15 | Eingeleitet | Stifel | Buy |
| 2019-07-25 | Bestätigt | Needham | Buy |
| 2019-07-16 | Herabstufung | Needham | Strong Buy → Buy |
| 2019-05-30 | Eingeleitet | Wolfe Research | Outperform |
| 2019-05-23 | Bestätigt | Needham | Strong Buy |
| 2019-04-22 | Bestätigt | Needham | Strong Buy |
| 2019-04-16 | Bestätigt | BofA/Merrill | Buy |
Alle ansehen
Thermo Fisher Scientific Inc Aktie (TMO) Neueste Nachrichten
Thermo Fisher said to eye $10B takeover of clinical trial software firm Clario - Seeking Alpha
Thermo Fisher Scientific inaugurates expanded R&D centre of excellence in Bengaluru - ETHRWorld.com
14-year-old Combines Origami and Physics to Engineer - GlobeNewswire
Thermo Fisher nears $10 billion takeover of Clario, FT reports - Reuters
14-year-old Combines Origami and Physics to Engineer Foldable Structures for Disaster Relief Shelters; Wins $25,000 Top Award at Thermo Fisher Scientific Junior Innovators Challenge - GlobeNewswire Inc.
Thermo Fisher nears $10 bln deal to acquire Clario, FT reports - Investing.com
Thermo Fisher nears $10 billion takeover of drug trial software maker ClarioFT - MarketScreener
Insider Sell: Gianluca Pettiti Sells Shares of Thermo Fisher Sci - GuruFocus
Thermo Fisher Scientific invests ₹160 cr to expand Bengaluru R&D centre - BusinessLine
Thermo Fisher Scientific Enables Semiconductor Manufacturers to See the Unseen with Helios MX1 PFIB-SEM - The Joplin Globe
Thermo Fisher: Measuring Clinical Supply Chain Emissions - Supply Chain Digital Magazine
Morgan Stanley Raises Price Target on Thermo Fisher Scientific to $656 From $560, Keeps Overweight Rating - MarketScreener
Thermo Fisher invests Rs 160 crore to expand Bengaluru R&D centre - Moneycontrol
Is Thermo Fisher Scientific’s Stock Rally Justified After Strategic Growth Initiatives in 2025? - simplywall.st
Thermo Fisher Enhances India's Biotechnology Landscape with R&D Expansion - Devdiscourse
Thermo Fisher invests ₹160 crore to expand Bengaluru R&D facility, to create 100 jobs - ET HealthWorld
Thermo Fisher Scientific invests Rs. 160 crore, Bengaluru R&D will create over 100 jobs - Pharmabiz.com
Thermo Fisher Scientific inaugurates expanded R&D Centre of Excellence in Bengaluru - Express Pharma
Thermo Fisher Scientific Showcases Enhanced Accelerator™ Drug Development Capabilities and OpenAI Strategic Collaboration at CPHI Frankfurt 2025 - BioSpace
Published on: 2025-10-27 23:39:59 - newser.com
Will Thermo Fisher Scientific Inc. (TN8) stock outperform benchmarksWeekly Gains Report & Risk Managed Investment Strategies - Fundação Cultural do Pará
Will Thermo Fisher Scientific Inc. stock outperform Nasdaq indexMarket Activity Report & Risk Controlled Daily Plans - Fundação Cultural do Pará
Thermo Fisher Scientific invests Rs 160 Cr to advance innovation in antibody research and manufacturing - IndiaMedToday
Price momentum metrics for Thermo Fisher Scientific Inc. explainedCEO Change & Long-Term Capital Growth Strategies - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock remains top ratedJuly 2025 Chart Watch & High Accuracy Swing Trade Signals - Fundação Cultural do Pará
OpenAI lands new pharma deals with Thermo Fisher and Lundbeck - FirstWord Pharma
Thermo Fisher Scientific invests Rs 160 Cr+ to expand Bengaluru R&D facility - BioSpectrum India
Thermo Fisher’s Pullback Is Setting Up Its Next Phase of Growth - The Globe and Mail
Thermo Fisher analysis stations target 97% copper recovery - Mining Magazine
Rheometer Market By Leading Key Players, Opportunities - openPR.com
Industry Focus eBookForensics & Toxicology (1st edition) - News-Medical
How to use Fibonacci retracement on Thermo Fisher Scientific Inc.Global Markets & AI Driven Price Predictions - newser.com
What makes Thermo Fisher Scientific Inc. (TN8) stock appealing to growth investors2025 Technical Overview & Weekly High Return Forecasts - newser.com
Why analysts recommend Thermo Fisher Scientific Inc. (Common Stock) (TN80) stockJuly 2025 Drop Watch & Weekly Setup with High ROI Potential - newser.com
Price action breakdown for Thermo Fisher Scientific Inc.Insider Buying & Long Hold Capital Preservation Plans - newser.com
Chart overlay techniques for tracking Thermo Fisher Scientific Inc.2025 Dividend Review & Breakout Confirmation Trade Signals - newser.com
Candlestick signals on Thermo Fisher Scientific Inc. stock todayDip Buying & Low Drawdown Trading Techniques - newser.com
Visual analytics tools that track Thermo Fisher Scientific Inc. performance2025 Performance Recap & Comprehensive Market Scan Insights - newser.com
Thermo Fisher Scientific (TMO) Is Up 6.2% After Beating Q3 Forecasts and Announcing OpenAI Collaboration - simplywall.st
Is Thermo Fisher Scientific Inc. (TN8) stock considered safe havenJuly 2025 Patterns & Stock Market Timing Techniques - newser.com
Why Thermo Fisher Scientific Inc. stock is rated strong buyJuly 2025 Spike Watch & Growth Focused Investment Plans - newser.com
Why Thermo Fisher Scientific Inc. (TN8) stock fits value portfoliosPortfolio Update Summary & Daily Stock Momentum Reports - newser.com
Is Thermo Fisher Scientific Inc. stock a top pick in earnings seasonTrade Ideas & Safe Swing Trade Setup Alerts - newser.com
Thermo Fisher Scientific: More Upside Likely As Headwinds Continue To Fade And Valuation Still Attractive - Seeking Alpha
Thermo Fisher Scientific’s Valuation: Assessing Upside After Strong Q3, AI Partnerships, and Raised Guidance - simplywall.st
Jim Cramer on Thermo Fisher: “Maybe This Stock Can Finally Get its Groove Back” - Insider Monkey
Published on: 2025-10-24 17:56:28 - newser.com
Volatility clustering patterns for Thermo Fisher Scientific Inc.Index Update & Accurate Entry/Exit Alerts - newser.com
Finanzdaten der Thermo Fisher Scientific Inc-Aktie (TMO)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.86%
0.32%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):